HEADER TRANSCRIPTION 01-JUL-11 3SP9 TITLE STRUCTURAL BASIS FOR ILOPROST AS A DUAL PPARALPHA/DELTA AGONIST COMPND MOL_ID: 1; COMPND 2 MOLECULE: PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR DELTA; COMPND 3 CHAIN: A, B; COMPND 4 FRAGMENT: LIGAND BINDING DOMAIN; COMPND 5 SYNONYM: PPAR-DELTA, NUCI, NUCLEAR HORMONE RECEPTOR 1, NUC1, NUCLEAR COMPND 6 RECEPTOR SUBFAMILY 1 GROUP C MEMBER 2, PEROXISOME PROLIFERATOR- COMPND 7 ACTIVATED RECEPTOR BETA, PPAR-BETA; COMPND 8 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: PPARD, NR1C2, PPARB; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS NUCLEAR RECEPTOR LBD, NUCLEAR RECEPTOR FOLD, LIGAND BINDING, GENE KEYWDS 2 TRANSCRIPTION, DRUG BINDING, TRANSCRIPTION EXPDTA X-RAY DIFFRACTION AUTHOR H.RONG,Y.LI REVDAT 3 16-APR-14 3SP9 1 REMARK REVDAT 2 20-JUN-12 3SP9 1 JRNL REVDAT 1 20-JUL-11 3SP9 0 JRNL AUTH L.JIN,S.LIN,H.RONG,S.ZHENG,S.JIN,R.WANG,Y.LI JRNL TITL STRUCTURAL BASIS FOR ILOPROST AS A DUAL PEROXISOME JRNL TITL 2 PROLIFERATOR-ACTIVATED RECEPTOR ALPHA/DELTA AGONIST. JRNL REF J.BIOL.CHEM. V. 286 31473 2011 JRNL REFN ISSN 0021-9258 JRNL PMID 21775429 JRNL DOI 10.1074/JBC.M111.266023 REMARK 2 REMARK 2 RESOLUTION. 2.30 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX (PHENIX.REFINE: 1.5_2) REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VICENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE- REMARK 3 : KUNSTLEVE,LI-WEI HUNG,ROBERT IMMORMINO, REMARK 3 : TOM IOERGER,AIRLIE MCCOY,ERIK MCKEE,NIGEL REMARK 3 : MORIARTY,REETAL PAI,RANDY READ,JANE REMARK 3 : RICHARDSON,DAVID RICHARDSON,TOD ROMO,JIM REMARK 3 : SACCHETTINI,NICHOLAS SAUTER,JACOB SMITH, REMARK 3 : LAURENT STORONI,TOM TERWILLIGER,PETER REMARK 3 : ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : ML REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.30 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 36.88 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.360 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.3 REMARK 3 NUMBER OF REFLECTIONS : 26190 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.198 REMARK 3 R VALUE (WORKING SET) : 0.195 REMARK 3 FREE R VALUE : 0.253 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.100 REMARK 3 FREE R VALUE TEST SET COUNT : 1335 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 36.8886 - 4.9517 0.99 2513 148 0.1898 0.2278 REMARK 3 2 4.9517 - 3.9317 0.99 2520 113 0.1609 0.2173 REMARK 3 3 3.9317 - 3.4351 0.94 2346 138 0.1771 0.2379 REMARK 3 4 3.4351 - 3.1212 1.00 2492 150 0.1984 0.2583 REMARK 3 5 3.1212 - 2.8976 1.00 2483 125 0.1933 0.2370 REMARK 3 6 2.8976 - 2.7268 1.00 2513 120 0.1999 0.2616 REMARK 3 7 2.7268 - 2.5903 1.00 2524 128 0.2034 0.2681 REMARK 3 8 2.5903 - 2.4776 1.00 2485 140 0.2096 0.3031 REMARK 3 9 2.4776 - 2.3822 1.00 2493 138 0.2107 0.2447 REMARK 3 10 2.3822 - 2.3000 1.00 2487 135 0.2233 0.3114 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : 0.32 REMARK 3 B_SOL : 27.78 REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.300 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 24.320 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -0.25270 REMARK 3 B22 (A**2) : 0.17290 REMARK 3 B33 (A**2) : 0.91360 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.23800 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.008 4481 REMARK 3 ANGLE : 1.179 6058 REMARK 3 CHIRALITY : 0.078 695 REMARK 3 PLANARITY : 0.004 762 REMARK 3 DIHEDRAL : 18.060 1668 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 3SP9 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 08-JUL-11. REMARK 100 THE RCSB ID CODE IS RCSB066482. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 15-JUN-10 REMARK 200 TEMPERATURE (KELVIN) : 200 REMARK 200 PH : 6.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : APS REMARK 200 BEAMLINE : 21-ID-F REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.97857 REMARK 200 MONOCHROMATOR : DIAMOND [111] REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : MARMOSAIC 225 MM CCD REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000 REMARK 200 DATA SCALING SOFTWARE : HKL-2000 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 26191 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.300 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 2.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.0 REMARK 200 DATA REDUNDANCY : NULL REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : NULL REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.30 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.38 REMARK 200 COMPLETENESS FOR SHELL (%) : 99.0 REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: MOLREP REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 47.49 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.34 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 10% PEG3350, PH 6.5, VAPOR DIFFUSION, REMARK 280 HANGING DROP, TEMPERATURE 298K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 55.95250 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 HIS A 161 REMARK 465 HIS A 162 REMARK 465 HIS A 163 REMARK 465 HIS A 164 REMARK 465 HIS A 165 REMARK 465 HIS A 166 REMARK 465 LEU A 167 REMARK 465 VAL A 168 REMARK 465 PRO A 169 REMARK 465 ARG A 170 REMARK 465 GLY A 171 REMARK 465 SER A 172 REMARK 465 HIS B 161 REMARK 465 HIS B 162 REMARK 465 HIS B 163 REMARK 465 HIS B 164 REMARK 465 HIS B 165 REMARK 465 HIS B 166 REMARK 465 LEU B 167 REMARK 465 VAL B 168 REMARK 465 PRO B 169 REMARK 465 ARG B 170 REMARK 465 GLY B 171 REMARK 465 SER B 172 REMARK 465 ALA B 205 REMARK 465 SER B 206 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 O ALA A 173 O HOH A 70 2.14 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND LENGTHS REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,2(A3,1X,A1,I4,A1,1X,A4,3X),1X,F6.3) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 RES CSSEQI ATM2 DEVIATION REMARK 500 SER A 206 N SER A 206 CA -0.131 REMARK 500 GLU A 315 CB GLU A 315 CG -0.150 REMARK 500 GLU A 315 CD GLU A 315 OE1 -0.152 REMARK 500 GLU A 315 CD GLU A 315 OE2 -0.131 REMARK 500 GLU A 315 C GLU A 315 O -0.128 REMARK 500 HIS B 207 C HIS B 207 O -0.118 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 GLU A 315 OE1 - CD - OE2 ANGL. DEV. = -13.2 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASP A 174 -125.13 47.86 REMARK 500 SER A 206 -69.42 -94.35 REMARK 500 HIS A 207 -63.09 65.37 REMARK 500 LYS A 224 56.83 -100.56 REMARK 500 SER A 269 -6.18 82.30 REMARK 500 LEU A 357 41.45 -89.13 REMARK 500 ASP B 174 -134.39 62.91 REMARK 500 LYS B 224 82.84 -154.04 REMARK 500 SER B 269 -17.73 77.23 REMARK 500 LEU B 357 42.06 -89.20 REMARK 500 GLU B 424 55.81 -108.86 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: NON-CIS, NON-TRANS REMARK 500 REMARK 500 THE FOLLOWING PEPTIDE BONDS DEVIATE SIGNIFICANTLY FROM BOTH REMARK 500 CIS AND TRANS CONFORMATION. CIS BONDS, IF ANY, ARE LISTED REMARK 500 ON CISPEP RECORDS. TRANS IS DEFINED AS 180 +/- 30 AND REMARK 500 CIS IS DEFINED AS 0 +/- 30 DEGREES. REMARK 500 MODEL OMEGA REMARK 500 ALA A 205 SER A 206 -143.39 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CHIRAL CENTERS REMARK 500 REMARK 500 UNEXPECTED CONFIGURATION OF THE FOLLOWING CHIRAL REMARK 500 CENTER(S) USING IMPROPER CA--C--CB--N CHIRALITY REMARK 500 FOR AMINO ACIDS AND C1'--O4'--N1(N9)--C2' FOR REMARK 500 NUCLEIC ACIDS OR EQUIVALENT ANGLE REMARK 500 M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,6X,F5.1,6X,A1,10X,A1,3X,A16) REMARK 500 REMARK 500 M RES CSSEQI IMPROPER EXPECTED FOUND DETAILS REMARK 500 HIS A 207 23.1 L L OUTSIDE RANGE REMARK 500 REMARK 500 REMARK: NULL REMARK 525 REMARK 525 SOLVENT REMARK 525 REMARK 525 THE SOLVENT MOLECULES HAVE CHAIN IDENTIFIERS THAT REMARK 525 INDICATE THE POLYMER CHAIN WITH WHICH THEY ARE MOST REMARK 525 CLOSELY ASSOCIATED. THE REMARK LISTS ALL THE SOLVENT REMARK 525 MOLECULES WHICH ARE MORE THAN 5A AWAY FROM THE REMARK 525 NEAREST POLYMER CHAIN (M = MODEL NUMBER; REMARK 525 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE REMARK 525 NUMBER; I=INSERTION CODE): REMARK 525 REMARK 525 M RES CSSEQI REMARK 525 HOH B 564 DISTANCE = 5.29 ANGSTROMS REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE IL2 A 901 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE IL2 B 901 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 3SP6 RELATED DB: PDB DBREF 3SP9 A 173 441 UNP Q03181 PPARD_HUMAN 173 441 DBREF 3SP9 B 173 441 UNP Q03181 PPARD_HUMAN 173 441 SEQADV 3SP9 HIS A 161 UNP Q03181 EXPRESSION TAG SEQADV 3SP9 HIS A 162 UNP Q03181 EXPRESSION TAG SEQADV 3SP9 HIS A 163 UNP Q03181 EXPRESSION TAG SEQADV 3SP9 HIS A 164 UNP Q03181 EXPRESSION TAG SEQADV 3SP9 HIS A 165 UNP Q03181 EXPRESSION TAG SEQADV 3SP9 HIS A 166 UNP Q03181 EXPRESSION TAG SEQADV 3SP9 LEU A 167 UNP Q03181 EXPRESSION TAG SEQADV 3SP9 VAL A 168 UNP Q03181 EXPRESSION TAG SEQADV 3SP9 PRO A 169 UNP Q03181 EXPRESSION TAG SEQADV 3SP9 ARG A 170 UNP Q03181 EXPRESSION TAG SEQADV 3SP9 GLY A 171 UNP Q03181 EXPRESSION TAG SEQADV 3SP9 SER A 172 UNP Q03181 EXPRESSION TAG SEQADV 3SP9 HIS B 161 UNP Q03181 EXPRESSION TAG SEQADV 3SP9 HIS B 162 UNP Q03181 EXPRESSION TAG SEQADV 3SP9 HIS B 163 UNP Q03181 EXPRESSION TAG SEQADV 3SP9 HIS B 164 UNP Q03181 EXPRESSION TAG SEQADV 3SP9 HIS B 165 UNP Q03181 EXPRESSION TAG SEQADV 3SP9 HIS B 166 UNP Q03181 EXPRESSION TAG SEQADV 3SP9 LEU B 167 UNP Q03181 EXPRESSION TAG SEQADV 3SP9 VAL B 168 UNP Q03181 EXPRESSION TAG SEQADV 3SP9 PRO B 169 UNP Q03181 EXPRESSION TAG SEQADV 3SP9 ARG B 170 UNP Q03181 EXPRESSION TAG SEQADV 3SP9 GLY B 171 UNP Q03181 EXPRESSION TAG SEQADV 3SP9 SER B 172 UNP Q03181 EXPRESSION TAG SEQRES 1 A 281 HIS HIS HIS HIS HIS HIS LEU VAL PRO ARG GLY SER ALA SEQRES 2 A 281 ASP LEU LYS ALA PHE SER LYS HIS ILE TYR ASN ALA TYR SEQRES 3 A 281 LEU LYS ASN PHE ASN MET THR LYS LYS LYS ALA ARG SER SEQRES 4 A 281 ILE LEU THR GLY LYS ALA SER HIS THR ALA PRO PHE VAL SEQRES 5 A 281 ILE HIS ASP ILE GLU THR LEU TRP GLN ALA GLU LYS GLY SEQRES 6 A 281 LEU VAL TRP LYS GLN LEU VAL ASN GLY LEU PRO PRO TYR SEQRES 7 A 281 LYS GLU ILE SER VAL HIS VAL PHE TYR ARG CYS GLN CYS SEQRES 8 A 281 THR THR VAL GLU THR VAL ARG GLU LEU THR GLU PHE ALA SEQRES 9 A 281 LYS SER ILE PRO SER PHE SER SER LEU PHE LEU ASN ASP SEQRES 10 A 281 GLN VAL THR LEU LEU LYS TYR GLY VAL HIS GLU ALA ILE SEQRES 11 A 281 PHE ALA MET LEU ALA SER ILE VAL ASN LYS ASP GLY LEU SEQRES 12 A 281 LEU VAL ALA ASN GLY SER GLY PHE VAL THR ARG GLU PHE SEQRES 13 A 281 LEU ARG SER LEU ARG LYS PRO PHE SER ASP ILE ILE GLU SEQRES 14 A 281 PRO LYS PHE GLU PHE ALA VAL LYS PHE ASN ALA LEU GLU SEQRES 15 A 281 LEU ASP ASP SER ASP LEU ALA LEU PHE ILE ALA ALA ILE SEQRES 16 A 281 ILE LEU CYS GLY ASP ARG PRO GLY LEU MET ASN VAL PRO SEQRES 17 A 281 ARG VAL GLU ALA ILE GLN ASP THR ILE LEU ARG ALA LEU SEQRES 18 A 281 GLU PHE HIS LEU GLN ALA ASN HIS PRO ASP ALA GLN TYR SEQRES 19 A 281 LEU PHE PRO LYS LEU LEU GLN LYS MET ALA ASP LEU ARG SEQRES 20 A 281 GLN LEU VAL THR GLU HIS ALA GLN MET MET GLN ARG ILE SEQRES 21 A 281 LYS LYS THR GLU THR GLU THR SER LEU HIS PRO LEU LEU SEQRES 22 A 281 GLN GLU ILE TYR LYS ASP MET TYR SEQRES 1 B 281 HIS HIS HIS HIS HIS HIS LEU VAL PRO ARG GLY SER ALA SEQRES 2 B 281 ASP LEU LYS ALA PHE SER LYS HIS ILE TYR ASN ALA TYR SEQRES 3 B 281 LEU LYS ASN PHE ASN MET THR LYS LYS LYS ALA ARG SER SEQRES 4 B 281 ILE LEU THR GLY LYS ALA SER HIS THR ALA PRO PHE VAL SEQRES 5 B 281 ILE HIS ASP ILE GLU THR LEU TRP GLN ALA GLU LYS GLY SEQRES 6 B 281 LEU VAL TRP LYS GLN LEU VAL ASN GLY LEU PRO PRO TYR SEQRES 7 B 281 LYS GLU ILE SER VAL HIS VAL PHE TYR ARG CYS GLN CYS SEQRES 8 B 281 THR THR VAL GLU THR VAL ARG GLU LEU THR GLU PHE ALA SEQRES 9 B 281 LYS SER ILE PRO SER PHE SER SER LEU PHE LEU ASN ASP SEQRES 10 B 281 GLN VAL THR LEU LEU LYS TYR GLY VAL HIS GLU ALA ILE SEQRES 11 B 281 PHE ALA MET LEU ALA SER ILE VAL ASN LYS ASP GLY LEU SEQRES 12 B 281 LEU VAL ALA ASN GLY SER GLY PHE VAL THR ARG GLU PHE SEQRES 13 B 281 LEU ARG SER LEU ARG LYS PRO PHE SER ASP ILE ILE GLU SEQRES 14 B 281 PRO LYS PHE GLU PHE ALA VAL LYS PHE ASN ALA LEU GLU SEQRES 15 B 281 LEU ASP ASP SER ASP LEU ALA LEU PHE ILE ALA ALA ILE SEQRES 16 B 281 ILE LEU CYS GLY ASP ARG PRO GLY LEU MET ASN VAL PRO SEQRES 17 B 281 ARG VAL GLU ALA ILE GLN ASP THR ILE LEU ARG ALA LEU SEQRES 18 B 281 GLU PHE HIS LEU GLN ALA ASN HIS PRO ASP ALA GLN TYR SEQRES 19 B 281 LEU PHE PRO LYS LEU LEU GLN LYS MET ALA ASP LEU ARG SEQRES 20 B 281 GLN LEU VAL THR GLU HIS ALA GLN MET MET GLN ARG ILE SEQRES 21 B 281 LYS LYS THR GLU THR GLU THR SER LEU HIS PRO LEU LEU SEQRES 22 B 281 GLN GLU ILE TYR LYS ASP MET TYR HET IL2 A 901 26 HET IL2 B 901 26 HETNAM IL2 (5E)-5-[(3AS,4R,5R,6AS)-5-HYDROXY-4-[(1E,3S,4R)-3- HETNAM 2 IL2 HYDROXY-4-METHYLOCT-1-EN-6-YN-1-YL]HEXAHYDROPENTALEN- HETNAM 3 IL2 2(1H)-YLIDENE]PENTANOIC ACID FORMUL 3 IL2 2(C22 H32 O4) FORMUL 5 HOH *385(H2 O) HELIX 1 1 ASP A 174 PHE A 190 1 17 HELIX 2 2 THR A 193 THR A 202 1 10 HELIX 3 3 ASP A 215 LYS A 224 1 10 HELIX 4 4 GLU A 240 LYS A 265 1 26 HELIX 5 5 SER A 269 LEU A 273 5 5 HELIX 6 6 PHE A 274 ALA A 295 1 22 HELIX 7 7 SER A 296 VAL A 298 5 3 HELIX 8 8 ARG A 314 LEU A 320 1 7 HELIX 9 9 PRO A 323 ASN A 339 1 17 HELIX 10 10 ALA A 340 GLU A 342 5 3 HELIX 11 11 ASP A 344 LEU A 357 1 14 HELIX 12 12 ASN A 366 HIS A 389 1 24 HELIX 13 13 TYR A 394 GLU A 424 1 31 HELIX 14 14 HIS A 430 LYS A 438 1 9 HELIX 15 15 ASP B 174 PHE B 190 1 17 HELIX 16 16 THR B 193 THR B 202 1 10 HELIX 17 17 ASP B 215 GLU B 223 1 9 HELIX 18 18 GLU B 240 SER B 266 1 27 HELIX 19 19 SER B 269 LEU B 273 5 5 HELIX 20 20 PHE B 274 ALA B 295 1 22 HELIX 21 21 ARG B 314 SER B 319 1 6 HELIX 22 22 PRO B 323 ASN B 339 1 17 HELIX 23 23 ALA B 340 GLU B 342 5 3 HELIX 24 24 ASP B 344 LEU B 357 1 14 HELIX 25 25 ASN B 366 HIS B 389 1 24 HELIX 26 26 TYR B 394 GLU B 424 1 31 HELIX 27 27 HIS B 430 LYS B 438 1 9 SHEET 1 A 3 PHE A 211 ILE A 213 0 SHEET 2 A 3 GLY A 310 THR A 313 1 O PHE A 311 N ILE A 213 SHEET 3 A 3 GLY A 302 VAL A 305 -1 N LEU A 303 O VAL A 312 SHEET 1 B 4 PHE B 211 ILE B 213 0 SHEET 2 B 4 GLY B 310 THR B 313 1 O PHE B 311 N ILE B 213 SHEET 3 B 4 GLY B 302 VAL B 305 -1 N LEU B 303 O VAL B 312 SHEET 4 B 4 VAL B 298 ASN B 299 -1 N ASN B 299 O GLY B 302 CISPEP 1 LYS A 322 PRO A 323 0 5.55 CISPEP 2 LYS B 322 PRO B 323 0 1.62 SITE 1 AC1 11 HOH A 37 HOH A 125 PHE A 246 ARG A 248 SITE 2 AC1 11 THR A 252 THR A 253 HIS A 287 ILE A 290 SITE 3 AC1 11 VAL A 305 HIS A 413 TYR A 437 SITE 1 AC2 13 HOH B 53 PHE B 246 ARG B 248 CYS B 249 SITE 2 AC2 13 THR B 252 THR B 253 HIS B 287 PHE B 291 SITE 3 AC2 13 VAL B 305 VAL B 312 HIS B 413 TYR B 437 SITE 4 AC2 13 HOH B 503 CRYST1 49.124 111.905 55.012 90.00 93.15 90.00 P 1 21 1 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.020357 0.000000 0.001120 0.00000 SCALE2 0.000000 0.008936 0.000000 0.00000 SCALE3 0.000000 0.000000 0.018205 0.00000 MASTER 369 0 2 27 7 0 7 6 0 0 0 44 END